secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2025-01-29T23:59:59+00:00
Accession:  0001493152-25-004104
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack CFO James Cardwell resigns; Peter Wulff appointed as CFO
-------------------------------------------------------------------

- James Cardwell resigned as CFO effective Jan 27, 2025; will remain as consultant for transition.
- Peter Wulff appointed CFO effective Jan 28, 2025; has 40+ years life sciences finance experience.
- Wulff's base salary: $300k for 2025, $450k thereafter; eligible for bonuses tied to financing milestones up to $262.5k total.
- Initial equity grant of options for 1.25% of outstanding common stock under 2024 Equity Incentive Plan.
- Wulff most recently CFO at Biological Dynamics; previously CFO at JenaValve Technology.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000149315225004104/0001493152-25-004104-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000149315225004104/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004104

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer